Ischemic Stroke, Major Bleeding and Death Following Oral Anticoagulation for Atrial Fibrillation Among Elderly Long-term Care Residents With Chronic Kidney Disease
Ziv Harel, Yuguang Kang, Kathryn Stirling, Joel G. Ray, Sara L. Win · 2026
Read Ischemic Stroke, Major Bleeding and Death Following Oral Anticoagulation for Atrial Fibrillation Among Elderly Long-term Care Residents With Chronic Kidney Disease by Ziv Harel, Yuguang Kang, Kathryn Stirling, Joel G. Ray, Sara L. Win (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13524551.txt.
Description
Ziv Harel and colleagues set out a 2026 population-based cohort study from Ontario on blood thinner use for atrial fibrillation in elderly long-term care residents who also have chronic kidney disease. Such residents face high stroke risk, yet only about half receive oral anticoagulants, partly because frail patients were largely excluded from the trials that guide practice.
Linked health datasets covering January 2011 to December 2022 supplied the cohort. Eligible residents were aged 66 or older, lived in long-term care, had kidney disease by filtration rate or dialysis, and had a validated atrial fibrillation diagnosis. New anticoagulant prescriptions after diagnosis formed the exposure. Outcomes were ischemic stroke, major bleeding, death soon after a bleed, and overall death, analyzed with adjusted time-varying hazard models. Ethics review was waived under Ontario privacy law for this authorized data use.
Catalog record
| CREATOR | Ziv Harel, Yuguang Kang, Kathryn Stirling, Joel G. Ray, Sara L. Win |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 11868 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |